J Servilio. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AIDS-Related Opportunistic Infections/drug therapyAIDS-Related Opportunistic Infections/mortalityAIDS-Related Opportunistic Infections/transmissionDrug Resistance, MicrobialDrug Therapy, CombinationEthambutol/therapeutic useHumansIsoniazid/therapeutic useNew York/epidemiologyPyrazinamide/therapeutic useRecurrenceRifampin/therapeutic useSurvival RateThalidomide/therapeutic useTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/mortalityTuberculosis, Pulmonary/transmissionTumor Necrosis Factor-alpha/drug effects
Substances: See more » Tumor Necrosis Factor-alphaPyrazinamideThalidomideEthambutolIsoniazidRifampin
Year: 1995 PMID: 11362673
Source DB: PubMed Journal: Posit Aware ISSN: 1523-2883